Mumbai, India , has emerged as a prominent global center for the production of Budesonide Active Pharmaceutical Ingredient (API), with CAS No. 51333-22-3. Several well-known companies are dedicated to the synthesis and distribution of this key corticocopyright. Such manufacturers adhere to string